Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1994 4
1995 3
1997 1
1998 1
2000 1
2001 1
2002 3
2003 2
2004 2
2005 1
2006 5
2007 4
2008 11
2009 5
2010 5
2011 13
2012 5
2013 1
2014 4
2015 4
2016 7
2017 7
2018 3
2019 5
2020 7
2021 7
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

PubMed for id: 4102

102 results

Results by year

Filters applied: . Clear all
Page 1
Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma.
Craig AJ, Garcia-Lezana T, Ruiz de Galarreta M, Villacorta-Martin C, Kozlova EG, Martins-Filho SN, von Felden J, Ahsen ME, Bresnahan E, Hernandez-Meza G, Labgaa I, D'Avola D, Schwartz M, Llovet JM, Sia D, Thung S, Losic B, Lujambio A, Villanueva A. Craig AJ, et al. PLoS Genet. 2021 Jun 24;17(6):e1009589. doi: 10.1371/journal.pgen.1009589. eCollection 2021 Jun. PLoS Genet. 2021. PMID: 34166362 Free PMC article.
Re-examination of MAGE-A3 as a T-cell Therapeutic Target.
Martin AD, Wang X, Sandberg ML, Negri KR, Wu ML, Toledo Warshaviak D, Gabrelow GB, McElvain ME, Lee B, Daris ME, Xu H, Kamb A. Martin AD, et al. J Immunother. 2021 Apr 1;44(3):95-105. doi: 10.1097/CJI.0000000000000348. J Immunother. 2021. PMID: 33284140 Free PMC article.
Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3.
Lu YC, Parker LL, Lu T, Zheng Z, Toomey MA, White DE, Yao X, Li YF, Robbins PF, Feldman SA, van der Bruggen P, Klebanoff CA, Goff SL, Sherry RM, Kammula US, Yang JC, Rosenberg SA. Lu YC, et al. J Clin Oncol. 2017 Oct 10;35(29):3322-3329. doi: 10.1200/JCO.2017.74.5463. Epub 2017 Aug 15. J Clin Oncol. 2017. PMID: 28809608 Free PMC article. Clinical Trial.
102 results